Last updated: February 27, 2026
What is NDC 50474-0470?
NDC 50474-0470 corresponds to [drug name, if available], a medication marketed primarily in the context of [indication or therapeutic class, if known]. It is manufactured by [manufacturer name, if available] and is available in [formulation, strength, route of administration]. Market entry was recorded around [date], with regulatory approval from [agency].
Market Fundamentals: Demand and Supply Drivers
Market Size and Therapeutic Landscape
The drug operates within a niche segment characterized by [target patient population, prevalence, and treatment guidelines]. Prevalence of the targeted condition is estimated at [value], with annual treatment volumes of approximately [number] prescriptions based on [data source].
Key Competitors and Substitutes
Major competitors include:
- [Drug A]: Market share of [percentage]%, priced at [price] per dose.
- [Drug B]: Market share of [percentage]%, priced at [price] per dose.
Market share shifts depend heavily on efficacy, side-effect profile, and payer coverage.
Distribution and Reimbursement Trends
Reimbursement policies influence sales volume. As of [date], around [percentage]% of prescriptions received insurance coverage. Key payers, such as [payer names], set formularies that favor or restrict access based on [criteria].
Price Trends and Projections
Current Pricing Landscape
The listed average manufacturer price (AMP) is $[amount] per unit. Wholesale acquisition cost (WAC) stands at $[amount]. Insurance reimbursements average $[amount], with patient out-of-pocket costs varying by plan and cost-sharing structure.
Historical Price Changes
Since market entry, the price has fluctuated as follows:
| Year |
Price per dose |
Change (%) |
| 2021 |
$[amount] |
N/A |
| 2022 |
$[amount] |
[percentage]% increase/decrease |
| 2023 |
$[amount] |
[percentage]% increase/decrease |
Price Drivers
Factors affecting future price include:
- Competition introduction or patent expiry
- Changes in regulatory status
- Negotiations with payers
- Manufacturing cost adjustments
Forward Price Projections
Over the next 12 months, prices are expected to:
| Scenario |
Price per dose (USD) |
Assumptions |
| Base case |
$[amount] |
No major patent challenges, stable demand |
| Upside |
$[amount] |
Entry of new competitors, increased demand |
| Downside |
$[amount] |
Patent expiration, payer discounts |
Projections suggest a [percentage]% decrease or increase depending on competitive dynamics.
Regulatory and Patent Landscape
The last patent protection expires in [date], opening potential for generic entry. Current exclusivity status appears to be [status] as of [date]. Pending regulatory updates include [details] that could modify market access or pricing.
Strategic Implications
- Brand loyalty and clinical differentiation will influence pricing stability.
- Payer negotiations remain critical; rebates and discounts can impact net price.
- The generic entry timeline will significantly pressure prices.
Key Takeaways
- The drug faces a competitive environment with established players.
- Current pricing is approximately $[amount] per dose.
- Price projections suggest stability for the next year, with potential declines post-patent expiry.
- Payer negotiation and market entry of generics will be primary drivers of future pricing.
- Market size and demand are tied to disease prevalence and treatment guidelines.
FAQs
1. How does patent expiry impact drug price?
Patent expiry allows generic competitors to enter, typically causing prices to decline by 50-80% within 1-2 years.
2. What factors affect reimbursement rates?
Reimbursement depends on formulary placement, negotiated discounts, patient copay assistance programs, and policy updates.
3. Are there upcoming regulatory changes that could influence prices?
Yes, pending regulatory decisions or approval of biosimilars/generics can lead to price adjustments.
4. How does market competition influence pricing strategies?
Intense competition often results in price erosion, prompting manufacturers to focus on clinical differentiation or expand indications.
5. What is the typical timeframe for price changes post-market entry?
Prices tend to stabilize for the first 1-2 years and often decrease once generic versions launch or regulatory policies shift.
Citations
- [1] Drug product database, FDA. (2023). National Drug Code Directory.
- [2] IQVIA. (2023). Prescription drug market insights.
- [3] CMS. (2022). Medicare and Medicaid drug reimbursement policies.
- [4] EvaluatePharma. (2023). Global Market Forecasts.
- [5] U.S. Patent Office. (2023). Patent expiration timelines.
